CPA1 and infection: In addition, it was hypothesized that the administered non-pathogenic CpA and E. coli strains are not increasing disease severity after experimental infection with C. suis, but lead to a reduction of clinical signs due to their beneficial effect on the development of gut microbiota and gut immunity.